Earnings call scheduled for Q4FY26 and FY2025-26 results on May 7, 2026

Board & Shareholder Meetings View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.6%1-day move

₹406.70

prior close

₹406.85

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2+0.4-0.1-0.7-1.6+3.5+6.4+13.8+16.2+17.7+15.1+25.4+29.1—

Up moveDown movePending

AI summary

Thyrocare Technologies has scheduled an earnings conference call for Thursday, May 7, 2026, at 5:30 PM IST to discuss its audited financial results for the quarter and full financial year ended March 31, 2026 (Q4FY26/FY2025-26). Senior management including MD & CEO Rahul Guha, CFO Vikram Gupta, CCO Rajdeep Panwar, COO Dr. Ramesh Kinha, and IR Manager Preet Joshi will participate. Dial-in numbers and webcast link have been provided for analysts and investors.

Likely market impact

Upcoming results discussion may influence near-term stock sentiment; investors should watch for guidance and financial highlights shared on the call.